Cellebrite DI Ltd

Finanzas de Cellebrite DI Ltd (CLBT)

$12.230

+0.131 (+1.07%)Al cierre

Rentabilidad y márgenes de CLBT

Evaluating the bottom line, Cellebrite DI Ltd maintains a gross margin of 80.78%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 5.82%, while the net margin is 4.86%. These profitability ratios, combined with a Return on Equity (ROE) of 12.31%, provide a clear picture of how effectively CLBT converts its operational activities into shareholder value.

Comparativa sectorial de CLBT

In the context of the broader market, CLBT competes directly with industry leaders such as VIA and ALRM. With a market capitalization of $2.83B, it holds a significant position in the sector. When comparing efficiency, CLBT's gross margin of 80.78% stands against VIA's 39.63% and ALRM's 62.33%. Such benchmarking helps identify whether Cellebrite DI Ltd is trading at a premium or discount relative to its financial performance.

Desempeño financiero de Cellebrite DI Ltd

Cellebrite has shown strong revenue growth with Q2 2026 revenue at $131 million, a 16% increase year-over-year. However, net income has declined significantly, with Q2 2026 net income at $6.37 million, down from $20.7 million in Q4 2025.

Financials

FY2026Q2
YoY:
+15.77%
131.14M
Total Revenue
FY2026Q2
YoY:
-53.73%
7.63M
Operating Profit
FY2026Q2
YoY:
-67.29%
6.37M
Net Income after Tax
FY2026Q2
YoY:
-62.50%
0.03
EPS - Diluted
FY2026Q2
YoY:
-79.43%
5.96M
Free Cash Flow
FY2026Q2
YoY:
-4.28%
80.78
Gross Profit Margin - %
FY2026Q2
YoY:
-26.73%
25.00
FCF Margin - %
FY2026Q2
YoY:
-71.73%
4.86
Net Margin - %
FY2026Q2
12.45
ROIC

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar